What Transformation Capital does

Transformation Capital is a Boston-headquartered, healthcare-specialist growth equity and venture capital firm that provides capital, strategic guidance, and industry network access exclusively to digital health, health IT, and healthcare services companies. The firm, operating as Transformation Capital Partners, L.P. (with related advisory entity Transformation Capital Advisers), was founded circa 2017-2019 and is led by co-founder and managing partner Todd Cozzens alongside managing partners Jared Kesselheim, M.D. and Mike Dixon. It maintains a 24-person team split across an 11-member Investment Team, a 5-member Partner Acceleration Team that supports portfolio company operating priorities, and an 8-member Operations Team.

The firm has built a portfolio of more than 30 active and exited healthcare companies spanning virtual care (Sword Health, Grow Therapy, PlushCare), pharmacy benefit management (Capital Rx/Judi Health), clinical AI (Latent, Qualified Health, Alaffia Health, SmarterDx), life sciences compliance (Ketryx), data infrastructure (Datavant), practice technology (Tebra, Parachute Health), and value-based care (Groups Recover Together, Mosaic Health, Local Infusion). Notable outcomes include Sword Health reaching a $3B valuation, Grow Therapy reaching $3B valuation with over $1B in annual revenue, and exits via Health Catalyst IPO, SmarterDx (NMC acquisition), and Scientist.com (GHO Capital acquisition).

The business model follows standard private fund economics: Transformation Capital raises capital from institutional limited partners into privately offered funds (Transformation Capital Funds) and earns revenue through management fees on committed/invested capital plus carried interest on fund returns. Investment terms are negotiated privately via private placement memoranda and are not publicly disclosed. The firm's go-to-market is relationship-driven and healthcare-specific, relying on direct founder outreach, warm introductions from existing portfolio CEOs, healthcare executive referrals, and content marketing (Perspectives blog, Accelerating Impact newsletter) rather than mass-market channels.

Name

Transformation Capital

Legal name

Transformation Capital Partners, L.P.

Website

https://transformcap.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Boston-based healthcare-specialist growth equity firm providing capital and strategic guidance exclusively to digital health startups, managing a 30+ company portfolio with a 24-person team and exits including Health Catalyst IPO and SmarterDx.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital / Growth Equity

NAICS

Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394), Other Financial Vehicles (525990)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

akta.pro secondary industry

Technology & Software Growth Equity (FSANACAA)

Keywords

• Healthcare growth equity
• Digital health venture capital
• Healthcare IT investing
• Growth-stage healthcare funds
• Healthcare startup investment

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Venture capital fund management: Transformation Capital Partners, L.P. operates as a private investment advisor managing capital pools ("Transformation Capital Funds") on behalf of limited partners. Revenue is generated through typical private fund economics: management fees on committed/invested capital and carried interest (carried interest/profit participation) on fund returns. The firm explicitly states it provides investment advisory services only to privately offered funds and does not solicit services to the public.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Core offering

Transformation Capital is a healthcare-focused growth equity firm that invests exclusively in digital health, health IT, and healthcare services companies from Series A through growth stages. The firm provides capital from privately offered investment funds advised by Transformation Capital Advisers, combined with sector-specific strategic guidance, board-level involvement, and curated introductions to healthcare leaders across payers, providers, and health systems.

Product overview

Transformation Capital is a digital healthcare-focused venture capital investment firm rather than a software product company; its offering is growth-stage equity capital and strategic partnership support exclusively to healthcare companies. The firm does not maintain its own branded technology products, modules, or platforms — its website (transformcap.com) functions purely as informational, marketing, and investor-relations content, while operational services are delivered via a non-public limited-partner portal (InvestranDX). The publicly visible "offerings" are therefore its investment services and the curated portfolio of partner companies (e.g., Sword Health, Datavant, Grow Therapy, Capital Rx/Judi Health, Tebra, Alaffia, Latent, Qualified Health, Ketryx, SmarterDx, CodaMetrix, Parachute Health, Rad AI, Local Infusion, Solstice Health), with no unified in-house product platform binding them.

Differentiator

Problem solved

Functional benefit

Products and services

• Transformation Capital Funds (Privately Offered Investment Funds) Privately offered venture capital funds that invest exclusively in digital health, health IT, and healthcare services companies from Series A through growth stages. The funds are advised by Transformation Capital Advisers and accessed by limited partners via the InvestranDX limited partners portal.
• Growth-Stage Equity Investment Services Investment advisory services for healthcare startup founders and management teams, providing growth-stage equity capital combined with board-level involvement, sector-specific strategic guidance, and curated introductions to healthcare leaders across payers, providers, and health systems. Founders initiate contact via [email protected].

Quantifiable outcome

• Portfolio impact: Sword Health achieved 3B valuation across multiple funding rounds including $130M raise at $3B valuation in June 2024
• +9 more outcomes

Named customers15 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered flagship.

• Healthcare industry leaders (executives, payers, providers, health systems)flagshipStrategic or Co-development PartnerTransformation Capital's network of healthcare leaders is a core strategic asset. The firm explicitly states: 'Knowing who's who in healthcare matters. We help our partner companies connect to the right people at the right time for the right solution to drive forward progress.' This network serves as a referral and commercial-introduction channel for portfolio companies to accelerate customer acquisition and partnership formation.
• Healthcare founders and entrepreneursflagshipStrategic or Co-development PartnerTC partners 'in tandem with our partners and see their success as our success' — providing not just capital but 'proven experience they can benefit from, AND a network of healthcare leaders who can use their innovations to help transform the industry and provide feedback for continuous improvement.' This bidirectional relationship differentiates TC from typical financial-only VCs.

Scale indicators12 records

Recent moves18 records

Expansion highlights4 records

Direct peers

• Oak HC/FT: Healthcare- and fintech-dedicated growth equity firm with a similar investment stage focus (Series A through growth) and a deep operating-partner model. Directly comparable as a thesis-driven, sector-specialist growth investor backing digital health and healthcare services companies.
• Flare Capital Partners: Boston-based venture capital firm exclusively focused on healthcare technology and services. Frequently co-invests with TC (e.g., Qualified Health's $125M Series B), sharing a similar early-to-growth stage focus on digital health and provider/payer enablement.
• Frist Cressey Ventures: Healthcare-focused venture capital firm investing across early- and growth-stage digital health, services, and technology companies. Frequently co-invests alongside TC (Qualified Health Series B), with comparable sector specialization and portfolio support model.
• Town Hall Ventures: Healthcare-dedicated venture firm focused on companies transforming care for underserved and complex populations. Co-invested with TC in Qualified Health's $125M Series B and shares a similar thesis-driven, healthcare-only investment approach.
• Venrock: Long-tenured venture firm with a deep healthcare practice covering digital health, therapeutics, and diagnostics. Comparable as a thesis-driven healthcare investor with similar early-to-growth stage focus and a track record of healthcare exits.
• Echo Health Ventures: Strategic healthcare venture platform formed by Cambia Health Solutions and Mosaic Health Solutions. Invests across digital health and care delivery with a payer-aligned approach that mirrors TC's emphasis on payer/provider network leverage.

Broad incumbents

• General Catalyst: Large multi-stage venture firm with one of the most prominent dedicated healthcare practices (Health Assurance). Co-invested with TC in Latent's $80M Series A and pursues similar digital health, payer/provider, and AI-enabled healthcare themes at typically larger fund and check sizes.
• New Enterprise Associates (NEA): One of the largest venture firms with a longstanding healthcare practice. Led Qualified Health's $125M Series B in which TC participated, and overlaps with TC across digital health, payer technology, and provider enablement themes at scale.
• Andreessen Horowitz (a16z Bio + Health): Large venture firm with a dedicated Bio + Health fund actively investing across digital health, healthcare AI, and care delivery. Competitor for healthcare AI deals and broader digital health rounds, though it operates at materially larger fund and check sizes than TC.
• Bessemer Venture Partners: Large multi-stage venture firm with a dedicated healthcare practice covering digital health, tech-enabled services, and biotech. Overlaps with TC across growth-stage digital health and AI-enabled care delivery themes, typically writing larger checks.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/transformationcapital
• Xx.com/transformcptl

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments74 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Transformation Capital